Metabolic Bone Disease in the Neonatal Period and Its Later Sequelae

Pediatric Bone

Volumn , Issue , 2012, Pages 655-677

  Bishop, Nick ^a   Fewtrell, Mary ^b   Harvey, Nicholas C ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882916639     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382040-2.10024-3     Document Type: Chapter

References (174)

1. Ferrari S., Rizzoli R., Bonjour J.P. Genetic aspects of osteoporosis. Curr Opin Rheumatol 1999, 11:294-300.
2. Harvey N., Cooper C. The developmental origins of osteoporotic fracture. J Br Menopause Soc 2004, 10:29.
3. Gluckman P.D., Hanson M.A., Cooper C., Thornburg K.L. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008, 359:61-73.
4. Kanis J.A., Delmas P., Burckhardt P., Cooper C., Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1997, 7:390-406.
5. Sambrook P., Cooper C. Osteoporosis. Lancet 2006, 367:2010-2018.
6. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17:716-724.
7. Ferrari S., Rizzoli R., Slosman D., Bonjour J.P. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998, 83:358-361.
8. Wang Q., Alen M., Lyytikainen A., et al. Familial resemblance and diversity in bone mass and strength in the population are established during the first year of postnatal life. J Bone Miner Res 2010, 25:1512-1520.
9. Wang Q., Cheng S., Alen M., Seeman E. Bone's structural diversity in adult females is established before puberty. J Clin Endocrinol Metab 2009, 94:1555-1561.
10. Hernandez C.J., Beaupre G.S., Carter D.R. A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int 2003, 14:843-847.
11. Salle B.L., Glorieux F.H., Delvin E.E. Perinatal vitamin D metabolism. Biol Neonate 1988, 54:181-187.
12. Seki K., Furuya K., Makimura N., Mitsui C., Hirata J., Nagata I. Cord blood levels of calcium-regulating hormones and osteocalcin in premature infants. J Perinat Med 1994, 22:189-194.
13. Whitsett J.A., Ho M., Tsang R.C., Norman E.J., Adams K.G. Synthesis of 1,25-dihydroxyvitamin D3 by human placenta in vitro. J Clin Endocrinol Metab 1981, 53:484-488.
14. Ron M., Levitz M., Chuba J., Dancis J. Transfer of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 across the perfused human placenta. Am J Obstet Gynecol 1984, 148:370-374.
15. Koo W.W.K., Tsang R.C. Calcium, magnesium, phosphorus, and vitamin D. Nutritional Needs of the Preterm Infant 1993, 135-155. Williams and Wilkins, New York. R.C. Tsang, A. Lucas, R. Uauy, S. Zlotkin (Eds.).
16. Kovacs C.S., Chafe L.L., Fudge N.J., Friel J.K., Manley N.R. PTH regulates fetal blood calcium and skeletal mineralization independently of PTHrP. Endocrinology 2001, 142:4983-4993.
17. Lester G.E. Cholecalciferol and placental calcium transport. Fed Proc 1986, 45:2524-2527.
18. Kovacs C.S., Woodland M.L., Fudge N.J., Friel J.K. The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice. Am J Physiol Endocrinol Metab 2005, 289:E133-E144.
19. Kovacs C.S. Skeletal physiology: fetus and neonate. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 2003, 65-71. ASBMR, Washington. 5th ed. M.J. Favus (Ed.).
20. Care A.D., Caple I.W., Abbas S.K., Pickard D.W. The effect of fetal thyroparathyroidectomy on the transport of calcium across the ovine placenta to the fetus. Placenta 1986, 7:417-424.
21. Kovacs C.S., Lanske B., Hunzelman J.L., Guo J., Karaplis A.C., Kronenberg H.M. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci USA 1996, 93:15233-15238.
22. Kovacs C.S., Manley N.R., Moseley J.M., Martin T.J., Kronenberg H.M. Fetal parathyroids are not required to maintain placental calcium transport. J Clin Invest 2001, 107:1007-1015.
23. Ardawi M.S., Nasrat H.A., HS BAA Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol 1997, 137:402-409.
24. Belkacemi L., Bedard I., Simoneau L., Lafond J. Calcium channels, transporters and exchangers in placenta: a review. Cell Calcium 2005, 37:1-8.
25. Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E. Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. J Biol Chem 1993, 268:25993-26003.
26. Glazier J.D., Atkinson D.E., Thornburg K.L., et al. Gestational changes in Ca2+ transport across rat placenta and mRNA for calbindin9K and Ca(2+)-ATPase. Am J Physiol 1992, 263:R930-R935.
27. Kip S.N., Strehler E.E. Vitamin D3 upregulates plasma membrane Ca2+-ATPase expression and potentiates apico-basal Ca2+ flux in MDCK cells. Am J Physiol Renal Physiol 2004, 286:F363-F369.
28. Martin R., Harvey N.C., Crozier S.R., et al. Placental calcium transporter (PMCA3) gene expression predicts intrauterine bone mineral accrual. Bone 2007, 40:1203-1208.
29. Weir E.C., Philbrick W.M., Amling M., Neff L.A., Baron R., Broadus A.E. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 1996, 93:10240-10245.
30. Calvi L.M., Schipani E. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia. J Endocrinol Invest 2000, 23:545-554.
31. Iwamoto M., Jikko A., Murakami H., et al. Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem 1994, 269:17245-17251.
32. Kato Y., Shimazu A., Nakashima K., Suzuki F., Jikko A., Iwamoto M. Effects of parathyroid hormone and calcitonin on alkaline phosphatase activity and matrix calcification in rabbit growth-plate chondrocyte cultures. Endocrinology 1990, 127:114-118.
33. Vortkamp A., Lee K., Lanske B., Segre G.V., Kronenberg H.M., Tabin C.J. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 1996, 273:613-622.
34. Karaplis A.C., Luz A., Glowacki J., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994, 8:277-289.
35. Lanske B., Karaplis A.C., Lee K., et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996, 273:663-666.
36. Lanske B., Amling M., Neff L., Guiducci J., Baron R., Kronenberg H.M. Ablation of the PTHrP gene or the PTH/PTHrP receptor gene leads to distinct abnormalities in bone development. J Clin Invest 1999, 104:399-407.
37. Calvi L.M., Sims N.A., Hunzelman J.L., et al. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 2001, 107:277-286.
38. Antoniades L., MacGregor A.J., Andrew T., Spector T.D. Association of birth weight with osteoporosis and osteoarthritis in adult twins. Rheumatology (Oxford) 2003, 42:791-796.
39. Bagnoli F., Sardelli S., Vispi L., et al. [Serum calcitonin in full-term infants]. Boll Soc Ital Biol Sper 1982, 58:556-561.
40. Hillman L.S., Hoff N., Walgate J., Haddad J.G. Serum calcitonin concentrations in premature infants during the first 12 weeks of life. Calcif Tissue Int 1982, 34:470-473.
41. Romagnoli C., Zecca E., Tortorolo G., Diodato A., Fazzini G., Sorcini-Carta M. Plasma thyrocalcitonin and parathyroid hormone concentrations in early neonatal hypocalcaemia. Arch Dis Child 1987, 62:580-584.
42. Sann L., David L., Chayvialle J.A., Lasne Y., Bethenod M. Effect of early oral calcium supplementation on serum calcium and immunoreactive calcitonin concentration in preterm infants. Arch Dis Child 1980, 55:611-615.
43. Cooper L.J., Anast C.S. Circulating immunoreactive parathyroid hormone levels in premature infants and the response to calcium therapy. Acta Paediatr Scand 1985, 74:669-673.
44. Holtrop M.E., King G.J., Cox K.A., Reit B. Time-related changes in the ultrastructure of osteoclasts after injection of parathyroid hormone in young rats. Calcif Tissue Int 1979, 27:129-135.
45. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
46. Wright C., David L., Chapuy M.C., Delvin E., Putet G., Salle B.L. [Late neonatal hypocalcemia. Apropos of 33 cases treated with 1 alpha-hydroxycholecalciferol]. Pediatrie 1989, 44:289-295.
47. Anderson H.C. Matrix vesicle calcification: review and update. Bone and Mineral Research 1985, 109-150. Elsevier, Amsterdam.
48. Anderson H.C. Introduction to the second conference on matrix vesicle calcification. Metab Bone Dis Relat Res 1978, 1:83-87.
49. Simon D.R., Berman I., Howell D.S. Relationship of extracellular matrix vesicles to calcification in normal and healing rachitic epiphyseal cartilage. Anat Rec 1973, 176:167-179.
50. Widdowson E.M. Nutrition. Scientific Foundations of Paediatrics 1981, 41-43. Heinemann, London. 2nd ed. J.A. Davis, J. Dobbing (Eds.).
51. Bishop N.J. Bone mineralisation in preterm infants; effect of early diet. [MD] University of Manchester 1993.
52. Ziegler E.E., O'Donnell A.M., Nelson S.E. Body composition of the reference fetus. Growth 1976, 40:329-341.
53. Moyer-Mileur L.J., Brunstetter V., McNaught T.P., Gill G., Chan G.M. Daily physical activity program increases bone mineralization and growth in preterm very low birth weight infants. Pediatrics 2000, 106:1088-1092.
54. Kurl S., Heinonen K., Lansimies E. Effects of prematurity, intrauterine growth status, and early dexamethasone treatment on postnatal bone mineralisation. Arch Dis Child Fetal Neonatal Ed 2000, 83:F109-F111.
55. Weiler H.A., Paes B., Shah J.K., Atkinson S.A. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev 1997, 47:271-286.
56. Brunton J.A., Weiler H.A., Atkinson S.A. Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: validation using piglets and methodologic considerations in infants. Pediatr Res 1997, 41:590-596.
57. Crofton P.M., Shrivastava A., Wade J.C., et al. Effects of dexamethasone treatment on bone and collagen turnover in preterm infants with chronic lung disease. Pediatr Res 2000, 48:155-162.
58. Shrivastava A., Lyon A., McIntosh N. The effect of dexamethasone on growth, mineral balance and bone mineralisation in preterm infants with chronic lung disease. Eur J Pediatr 2000, 159:380-384.
59. Ylppo A. Das Wachstum der Fruhgeborenen von der Geburt bis zum Schulalter. Ztschr Kinderh 1919, 24:111.
60. Benjamin H.R., Gordon H.H., Marples E. Calcium and phosphorus requirements of premature infants. Am J Dis Child 1943, 65:412-425.
61. Von Sydow G. A study of the development of rickets in premature infants. Acta Paediatr 1946, 22:2.
62. Eek S., Gabrielson L.H. Prematurity and rickets. Pediatrics 1957, 20:63-77.
63. Lewin P.K., Reid M., Reilly B.J., Swyer P.R., Fraser D. Iatrogenic rickets in low-birth-weight infants. J Pediatr 1971, 78:207-210.
64. Tulloch A.L. Rickets in the premature. Med J Aust 1974, 2(1):137-140.
65. Gross S.J. Bone mineralization in preterm infants fed human milk with and without mineral supplementation. J Pediatr 1987, 111:450-458.
66. Chan G.M., Mileur L.J. Posthospitalization growth and bone mineral status of normal preterm infants. Feeding with mother's milk or standard formula. Am J Dis Child 1985, 139:896-898.
67. Greer F.R., McCormick A. Bone growth with low bone mineral content in very low birth weight premature infants. Pediatr Res 1986, 20:925-928.
68. Rowe J., Rowe D., Horak E., et al. Hypophosphatemia and hypercalciuria in small premature infants fed human milk: evidence for inadequate dietary phosphorus. J Pediatr 1984, 104:112-117.
69. Fewtrell M.S., Cole T.J., Bishop N.J., Lucas A. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease?. J Pediatr 2000, 137:668-673.
70. Lyon A.J., Hawkes D.J., Doran M., McIntosh N., Chan F. Bone mineralisation in preterm infants measured by dual energy radiographic densitometry. Arch Dis Child 1989, 64:919-923.
71. Lucas A., Gore S.M., Cole T.J., et al. Multicentre trial on feeding low birthweight infants: effects of diet on early growth. Arch Dis Child 1984, 59:722-730.
72. Minton S.D., Steichen J.J., Tsang R.C. Bone mineral content in term and preterm appropriate-for-gestational-age infants. J Pediatr 1979, 95:1037-1042.
73. James J.R., Congdon P.J., Truscott J., Horsman A., Arthur R. Osteopenia of prematurity. Arch Dis Child 1986, 61:871-876.
74. Pohlandt F. Hypothesis: myopia of prematurity is caused by postnatal bone mineral deficiency. Eur J Pediatr 1994, 153:234-236.
75. Pohlandt F., Mathers N. Bone mineral content of appropriate and light for gestational age preterm and term newborn infants. Acta Paediatr Scand 1989, 78:835-839.
76. Minton S.D., Steichen J.J., Tsang R.C. Decreased bone mineral content in small-for-gestational-age infants compared with appropriate-for-gestational-age infants: normal serum 25-hydroxyvitamin D and decreasing parathyroid hormone. Pediatrics 1983, 71:383-388.
77. Petersen S., Gotfredsen A., Knudsen F.U. Total body bone mineral in light-for-gestational-age infants and appropriate-for-gestational-age infants. Acta Paediatr Scand 1989, 78:347-350.
78. Greer F.R., Steichen J.J., Tsang R.C. Effects of increased calcium, phosphorus, and vitamin D intake on bone mineralization in very low-birth-weight infants fed formulas with Polycose and medium-chain triglycerides. J Pediatr 1982, 100:951-955.
79. Steichen J.J., Gratton T.L., Tsang R.C. Osteopenia of prematurity: the cause and possible treatment. J Pediatr 1980, 96:528-534.
80. Pittard W.B., Geddes K.M., Sutherland S.E., Miller M.C., Hollis B.W. Longitudinal changes in the bone mineral content of term and premature infants. Am J Dis Child 1990, 144:36-40.
81. Chan G.M., Mileur L., Hansen J.W. Calcium and phosphorus requirements in bone mineralization of preterm infants. J Pediatr 1988, 113:225-229.
82. Venkataraman P.S., Blick K.E. Effect of mineral supplementation of human milk on bone mineral content and trace element metabolism. J Pediatr 1988, 113:220-224.
83. DHSS The composition of mature human milk. Report on Health and Social Subjects No. 12 1977, HMSO, London.
84. DHSS. Artificial feeds for the young infant: Report on Health and Social Subjects No. 18. Report of the Committee on Medical Aspects of Food Policy. London: HMSO; 1980; Department of Health and Social Security. Present day practice in infant feeding, 1980. London: HMSO; 1981 (Reports on Health and Social Subjects, No 20.).
85. DHSS Present day practice in infant feeding, third report. Report on Health and Social Subjects No. 32 1988, HMSO, London.
86. Macy I.G., Kelly H.J., Sloan R.E. The composition of milks. Publication 254 1953, National Academy of Science, National Research Council, Washington DC.
87. Mettler A.E. Infant milk powder feeds compared on a common basis. Postgraduate Medical Journal 1976, 52(Suppl 8):3-20.
88. Greer F.R., McCormick A. Improved bone mineralization and growth in premature infants fed fortified own mother's milk. J Pediatr 1988, 112:961-969.
89. Pettifor J.M., Rajah R., Venter A., et al. Bone mineralization and mineral homeostasis in very low-birth-weight infants fed either human milk or fortified human milk. J Pediatr Gastroenterol Nutr 1989, 8:217-224.
90. Lapillonne A.A., Glorieux F.H., Salle B.L., et al. Mineral balance and whole body bone mineral content in very low-birth-weight infants. Acta Paediatr Suppl 1994, 405:117-122.
91. Wauben I.P., Atkinson S.A., Grad T.L., Shah J.K., Paes B. Moderate nutrient supplementation of mother's milk for preterm infants supports adequate bone mass and short-term growth: a randomized, controlled trial. Am J Clin Nutr 1998, 67:465-472.
92. Faerk J., Petersen S., Peitersen B., Michaelsen K.F. Diet and bone mineral content at term in premature infants. Pediatr Res 2000, 47:148-156.
93. McDevitt H., Tomlinson C., White M.P., Ahmed S.F. Changes in quantitative ultrasound in infants born at less than 32 weeks' gestation over the first 2 years of life: influence of clinical and biochemical changes. Calcif Tissue Int 2007, 81:263-269.
94. Fewtrell M.S., Loh K.L., Chomtho S., Kennedy K., Hawdon J., Khakoo A. Quantitative ultrasound (QUS): a useful tool for monitoring bone health in preterm infants?. Acta Paediatr 2008, 97:1625-1630.
95. Lucas A., Brooke O.G., Baker B.A., Bishop N., Morley R. High alkaline phosphatase activity and growth in preterm neonates. Arch Dis Child 1989, 64:902-909.
96. Beyers N., Alheit B., Taljaard J.F., Hall J.M., Hough S.F. High turnover osteopenia in preterm babies. Bone 1994, 15:5-13.
97. Bhandari V., Fall P., Raisz L., Rowe J. Potential biochemical growth markers in premature infants. Am J Perinatol 1999, 16:339-349.
98. Crofton P.M., Shrivastava A., Wade J.C., et al. Bone and collagen markers in preterm infants: relationship with growth and bone mineral content over the first 10 weeks of life. Pediatr Res 1999, 46:581-587.
99. Seibold-Weiger K., Wollmann H.A., Ranke M.B., Speer C.P. Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term. Pediatr Res 2000, 48:104-108.
100. Shiff Y., Eliakim A., Shainkin-Kestenbaum R., Arnon S., Lis M., Dolfin T. Measurements of bone turnover markers in premature infants. J Pediatr Endocrinol Metab 2001, 14:389-395.
101. Gfatter R., Braun F., Herkner K., Kohlross C., Hackl P. Urinary excretion of pyridinium crosslinks and N-terminal crosslinked peptide in preterm and term infants. Int J Clin Lab Res 1997, 27:238-243.
102. Smurthwaite D., Wright N.B., Russell S., Emmerson A.J., Mughal M.Z. How common are rib fractures in extremely low birth weight preterm infants?. Arch Dis Child Fetal Neonatal Ed 2009, 94:F138-F139.
103. Jones S., Bell M.J. Distal radius fracture in a premature infant with osteopenia caused by handling during intravenous cannulation. Injury 2002, 33:265-266.
104. Bishop N., Sprigg A., Dalton A. Unexplained fractures in infancy: looking for fragile bones. Arch Dis Child 2007, 92:251-256.
105. Salle B.L., Braillon P. Bone mineral content (BMC) of the lumbar spine in preterm infants: A longitudinal study during the first year of life. Pediatr Res 1992, 31:294A.
106. Koo W.W., Sherman R., Succop P., et al. Sequential bone mineral content in small preterm infants with and without fractures and rickets. J Bone Miner Res 1988, 3:193-197.
107. Congdon P.J., Horsman A., Ryan S.W., Truscott J.G., Durward H. Spontaneous resolution of bone mineral depletion in preterm infants. Arch Dis Child 1990, 65:1038-1042.
108. Abrams S.A., Schanler R.J., Garza C. Bone mineralization in former very low birth weight infants fed either human milk or commercial formula. J Pediatr 1988, 112:956-960.
109. Bishop N.J., King F.J., Lucas A. Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital. Arch Dis Child 1993, 68:573-578.
110. Brunton J.A., Saigal S., Atkinson S.A. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr 1998, 133:340-345.
111. Amir J., Katz K., Grunebaum M., Yosipovich Z., Wielunsky E., Reisner S.H. Fractures in premature infants. J Pediatr Orthop 1988, 8:41-44.
112. Fewtrell M.S., Prentice A., Cole T.J., Lucas A. Effects of growth during infancy and childhood on bone mineralization and turnover in preterm children aged 8-12 years. Acta Paediatr 2000, 89:148-153.
113. Fewtrell M.S., Williams J.E., Singhal A., Murgatroyd P.R., Fuller N., Lucas A. Early diet and peak bone mass: 20 year follow-up of a randomized trial of early diet in infants born preterm. Bone 2009, 45:142-149.
114. Rubinacci A., Sirtori P., Moro G., Galli L., Minoli I., Tessari L. Is there an impact of birth weight and early life nutrition on bone mineral content in preterm born infants and children?. Acta Paediatr 1993, 82:711-713.
115. Hori C., Tsukahara H., Fujii Y., et al. Bone mineral status in preterm-born children: assessment by dual-energy X-ray absorptiometry. Biol Neonate 1995, 68:254-258.
116. Helin I., Landin L.A., Nilsson B.E. Bone mineral content in preterm infants at age 4 to 16. Acta Paediatr Scand 1985, 74:264-267.
117. Kurl S., Heinonen K., Lansimies E., Launiala K. Determinants of bone mineral density in prematurely born children aged 6-7 years. Acta Paediatr 1998, 87:650-653.
118. Bowden L.S., Jones C.J., Ryan S.W. Bone mineralisation in ex-preterm infants aged 8 years. Eur J Pediatr 1999, 158:658-661.
119. Backstrom M.C., Maki R., Kuusela A.L., et al. The long-term effect of early mineral, vitamin D, and breast milk intake on bone mineral status in 9- to 11-year-old children born prematurely. J Pediatr Gastroenterol Nutr 1999, 29:575-582.
120. Bishop N.J., Dahlenburg S.L., Fewtrell M.S., Morley R., Lucas A. Early diet of preterm infants and bone mineralization at age five years. Acta Paediatr 1996, 85:230-236.
121. Fewtrell M.S., Prentice A., Jones S.C., et al. Bone mineralization and turnover in preterm infants at 8-12 years of age: the effect of early diet. J Bone Miner Res 1999, 14:810-820.
122. Dahlenburg S.L., Bishop N.J., Lucas A. Are preterm infants at risk for subsequent fractures?. Arch Dis Child 1989, 64:1384-1385.
123. Nutrition of the Preterm Infant. Scientific Basis and Practical Guidelines 2005, Digital Educational Publishing, Cincinnati. 2nd ed. R. Tsang, R. Uauy, B. Koletzko, S. Zlotkin (Eds.).
124. Agostoni C., Buonocore G., Carnielli V.P., et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010, 50:85-91.
125. Klein CJ, editor. Nutrient requirements for preterm infant formulas. J Nutr 2002;132:6SI.
126. Bishop N.J., Morley R., Day J.P., Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med 1997, 29(336):1557-1561.
127. Fewtrell M.S., Bishop N.J., Edmonds C.J., Isaacs E.B., Lucas A. Aluminum exposure from parenteral nutrition in preterm infants: bone health at 15-year follow-up. Pediatrics 2009, 124:1372-1379.
128. Poole R.L., Hintz S.R., Mackenzie N.I., Kerner J.A. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. J Parenter Enteral Nutr 2008, 32:242-246.
129. Poole R.L., Schiff L., Hintz S.R., Wong A., Mackenzie N., Kerner J.A. Aluminum content of parenteral nutrition in neonates: measured versus calculated levels. J Pediatr Gastroenterol Nutr 2010, 50:208-211.
130. MHRA. Available from: http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/ Safetywarningsandmessagesformedicines/CON093935.
131. Backstrom M.C., Maki R., Kuusela A.L., et al. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed 1999, 80:F161-F166.
132. Teaema F.H., Al Ansari K. Nineteen cases of symptomatic neonatal hypocalcemia secondary to vitamin D deficiency: a 2-year study. J Trop Pediatr 2010, 56:108-110.
133. Poomthavorn P., Ongphiphadhanakul B., Mahachoklertwattana P. Transient neonatal hypoparathyroidism in two siblings unmasking maternal normocalcemic hyperparathyroidism. Eur J Pediatr 2008, 167:431-434.
134. Santi M.D., Henry G.W., Douglas G.L. Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop 1994, 14:249-253.
135. Schanler R.J., Smith L.G., Burns P.A. Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest 1997, 43:236-241.
136. Egbuna O.I., Brown E.M. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 2008, 22:129-148.
137. Garabedian M. Hypocalcemia and chromosome 22q11 microdeletion. Genet Couns 1999, 10:389-394.
138. Delvin E.E., Salle B.L., Glorieux F.H., Adeleine P., David L.S. Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr 1986, 109:328-334.
139. Maiya S., Sullivan I., Allgrove J., et al. Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart 2008, 94:581-584.
140. Cooper C., Cawley M., Bhalla A., et al. Childhood growth, physical activity, and peak bone mass in women. J Bone Miner Res 1995, 10:940-947.
141. Dennison E.M., Arden N.K., Keen R.W., et al. Birthweight, vitamin D receptor genotype and the programming of osteoporosis. Paediatr Perinat Epidemiol 2001, 15:211-219.
142. Dennison E.M., Syddall H.E., Sayer A.A., Gilbody H.J., Cooper C. Birth weight and weight at 1 year are independent determinants of bone mass in the seventh decade: the Hertfordshire cohort study. Pediatr Res 2005, 57:582-586.
143. Javaid M.K., Lekamwasam S., Clark J., et al. Infant growth influences proximal femoral geometry in adulthood. J Bone Miner Res 2006, 21:508-512.
144. Oliver H., Jameson K.A., Sayer A.A., Cooper C., Dennison E.M. Growth in early life predicts bone strength in late adulthood: the Hertfordshire Cohort Study. Bone 2007, 41:400-405.
145. Cooper C., Eriksson J.G., Forsen T., Osmond C., Tuomilehto J., Barker D.J. Maternal height, childhood growth and risk of hip fracture in later life: a longitudinal study. Osteoporos Int 2001, 12:623-629.
146. Godfrey K., Walker-Bone K., Robinson S., et al. Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy. J Bone Miner Res 2001, 16:1694-1703.
147. Cole Z.A., Gale C.R., Javaid M.K., et al. Maternal dietary patterns during pregnancy and childhood bone mass: a longitudinal study. J Bone Miner Res 2009, 24:663-668.
148. Javaid M.K., Crozier S.R., Harvey N.C., et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367:36-43.
149. Harvey N.C., Javaid M.K., Poole J.R., et al. Paternal skeletal size predicts intrauterine bone mineral accrual. J Clin Endocrinol Metab 2008, 93:1676-1681.
150. Sayers A., Tobias J.H. Estimated maternal ultraviolet B exposure levels in pregnancy influence skeletal development of the child. J Clin Endocrinol Metab 2009, 94:765-771.
151. Ganpule A., Yajnik C.S., Fall C.H., et al. Bone mass in Indian children - relationships to maternal nutritional status and diet during pregnancy: the Pune Maternal Nutrition Study. J Clin Endocrinol Metab 2006, 91:2994-3001.
152. Javaid M.K., Godfrey K.M., Taylor P., et al. Umbilical cord leptin predicts neonatal bone mass. Calcif Tissue Int 2005, 76:341-347.
153. Javaid M.K., Godfrey K.M., Taylor P., et al. Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition. J Bone Miner Res 2004, 19:56-63.
154. Olney R.C., Mougey E.B. Expression of the components of the insulin-like growth factor axis across the growth-plate. Mol Cell Endocrinol 1999, 156:63-71.
155. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
156. Lepercq J., Challier J.C., Guerre-Millo M., Cauzac M., Vidal H. Hauguel-de Mouzon S. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001, 86:2409-2413.
157. Masuzaki H., Ogawa Y., Sagawa N., et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033.
158. Harvey N.C., Mahon P.A., Robinson S.M., et al. Different indices of fetal growth predict bone size and volumetric density at 4 years of age. J Bone Miner Res 2010, 25:920-927.
159. Phillips D.I., Barker D.J., Fall C.H., et al. Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?. J Clin Endocrinol Metab 1998, 83:757-760.
160. Dennison E., Hindmarsh P., Fall C., et al. Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men. J Clin Endocrinol Metab 1999, 84:3058-3063.
161. Fall C., Hindmarsh P., Dennison E., Kellingray S., Barker D., Cooper C. Programming of growth hormone secretion and bone mineral density in elderly men: a hypothesis. J Clin Endocrinol Metab 1998, 83:135-139.
162. Bateson P., Barker D., Clutton-Brock T., et al. Developmental plasticity and human health. Nature 2004, 22(430):419-421.
163. Lee T.M. Development of meadow voles is influenced postnatally by maternal photoperiodic history. Am J Physiol 1993, 265:R749-R755.
164. Bateson P. Fetal experience and good adult design. Int J Epidemiol 2001, 30:928-934.
165. Dennison E.M., Syddall H.E., Rodriguez S., Voropanov A., Day I.N., Cooper C. Polymorphism in the growth hormone gene, weight in infancy, and adult bone mass. J Clin Endocrinol Metab 2004, 89:4898-4903.
166. Jaenisch R., Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(Suppl.):245-254.
167. Morgan H.D., Santos F., Green K., Dean W., Reik W. Epigenetic reprogramming in mammals. Hum Mol Genet 2005, 14:R47-R58.
168. Gicquel C., El-Osta A., Le Bouc Y. Epigenetic regulation and fetal programming. Best Pract Res Clin Endocrinol Metab 2008, 22:1-16.
169. Gluckman P.D., Hanson M.A., Beedle A.S. Non-genomic transgenerational inheritance of disease risk. Bioessays 2007, 29:145-154.
170. Bird A. Perceptions of epigenetics. Nature 2007, 447:396-398.
171. Lillycrop K.A., Phillips E.S., Torrens C., Hanson M.A., Jackson A.A., Burdge G.C. Feeding pregnant rats a protein-restricted diet persistently alters the methylation of specific cytosines in the hepatic PPAR alpha promoter of the offspring. Br J Nutr 2008, 100:278-282.
172. Lillycrop K.A., Slater-Jefferies J.L., Hanson M.A., Godfrey K.M., Jackson A.A., Burdge G.C. Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 2007, 97:1064-1073.
173. Godfrey K.M., Lillycrop K.A., Burdge G.C., Gluckman P.D., Hanson M.A. Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res 2007, 61:5R-10R.
174. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002, 16:6-21.